Evidence map›Paper›PMID 37688243›Full record

ArticlePolymers2023

Bioactive and Biodegradable Polycaprolactone-Based Nanocomposite for Bone Repair Applications.

Hosein Emadi, Mehdi Karevan, Maryam Masoudi Rad, Sorour Sadeghzade, Farnoosh Pahlevanzadeh, Mohammad Khodaei, Saber Khayatzadeh, Saeid Lotfian

Abstract read
In one paragraph

Article in Polymers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Next Generation Calcium Nanomaterials: Disrupting Tumor CaInternational journal of nanomedicine · 2026
    Review
  3. Review
  4. Design and characterization of AgVOJournal of materials science. Materials in medicine · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hosein EmadiSchool of Mechanical Engineering, College of Engineering, University of Tehran, Tehran 14176-14411, Iran.
Mehdi KarevanDepartment of Mechanical Engineering, Isfahan University of Technology, Isfahan 84156-83111, Iran.
Maryam Masoudi RadDepartment of Chemical Engineering, Isfahan University of Technology, Isfahan 84156-83111, Iran.
Sorour SadeghzadeShenzhen Key Laboratory of Soft Mechanics & Smart Manufacturing, Department of Mechanics and Aerospace Engineering, Southern University of Science and Technology, Shenzhen 518055, China.ORCID 0000-0002-7034-4808
Farnoosh PahlevanzadehDepartment of Materials Engineering, Isfahan University of Technology, Isfahan 84156-83111, Iran.
Mohammad KhodaeiMaterials Engineering Group, Golpayegan College of Engineering, Isfahan University of Technology, Isfahan 84156-83111, Iran.
Saber KhayatzadehDepartment of Design and Mathematics, University of the West of England, Bristol BS16 1QY, UK.
Saeid LotfianFaculty of Engineering, University of Strathclyde, Glasgow G4 0LZ, UK.ORCID 0000-0001-8542-933X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study investigated the relationship between the structure and mechanical properties of polycaprolactone (PCL) nanocomposites reinforced with baghdadite, a newly introduced bioactive agent. The baghdadite nanoparticles were synthesised using the sol-gel method and incorporated into PCL films using the solvent casting technique. The results showed that adding baghdadite to PCL improved the nanocomposites' tensile strength and elastic modulus, consistent with the results obtained from the prediction models of mechanical properties. The tensile strength increased from 16 to 21 MPa, and the elastic modulus enhanced from 149 to 194 MPa with fillers compared to test specimens without fillers. The thermal properties of the nanocomposites were also improved, with the degradation temperature increasing from 388 °C to 402 °C when 10% baghdadite was added to PCL. Furthermore, it was found that the nanocomposites containing baghdadite showed an apatite-like layer on their surfaces when exposed to simulated body solution (SBF) for 28 days, especially in the film containing 20% nanoparticles (PB20), which exhibited higher apatite density. The addition of baghdadite nanoparticles into pure PCL also improved the viability of MG63 cells, increasing the viability percentage on day five from 103 in PCL to 136 in PB20. Additionally, PB20 showed a favourable degradation rate in PBS solution, increasing mass loss from 2.63 to 4.08 per cent over four weeks. Overall, this study provides valuable insights into the structure-property relationships of biodegradable-bioactive nanocomposites, particularly those reinforced with new bioactive agents.

Indexed as

baghdaditebiological propertiesbone tissue engineeringcomposite filmsmechanical propertiesnanocompositepolycaprolactonesolvent casting methodthermal properties

Identifiers

PMID37688243
PMCPMC10490551

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.